Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

Gabriele Magliano,Annarosa Cuccaro,Francesco D'Alo',Elena Maiolo,Silvia Bellesi,Stefan Hohaus,Andrea Bacigalupo,Livio Pagano

Mediterranean Journal of Hematology and Infectious Diseases（2021）

引用 0|浏览0

暂无评分

摘要

We discuss the case of a 74-year old male patient with mantle cell lymphoma, who faced severe CMV infection after the fifth cycle of first-line chemo-immunotherapy with a dose-reduced bendamustine and rituximab regimen.

查看译文

关键词

Mantle cell lymphoma,Bendamustine,CD4 lymphopenia,Non Hodgkin-s lymphoma,Cytomegalovirus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要